This compound is primarily used in the pharmaceutical industry as an intermediate in the synthesis of various therapeutic agents. Its structure is particularly valuable in the development of proton pump inhibitors (PPIs), which are widely prescribed for the treatment of gastrointestinal disorders such as acid reflux, peptic ulcers, and gastroesophageal reflux disease (GERD). The compound's benzimidazole moiety plays a critical role in binding to the proton pump in the stomach lining, effectively reducing acid production. Additionally, its methoxy and pyridinyl groups enhance its stability and bioavailability, making it a key component in the formulation of effective and long-lasting medications. Researchers also explore its potential in creating novel drugs targeting other conditions, leveraging its unique chemical properties for improved therapeutic outcomes.